Atenigron

Active substance

Atenolol + Chlortalidone

Strenght and pharmaceutical forms

100 mg + 25 mg tablets - 28 tablets

ATC

C07CB03 - Association of a hypotensive and a diuretic

Therapeutic Indications

Atenigron is suitable to treat essential hypertension in patients whose blood pressure is not adequately controlled by a single-agent therapy on atenolol or chlorthalidone alone.

Marketing Authorization Holder

Aesculapius Farmaceutici S.r.l.

Download area

Summary of Product Characteristics – Atenigron